StockData
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) stock

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.72−0.03 (-1.71%)

Close on Nov 17, 2026Market cap $36.18MP/E –Yield –

Grace Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Grace Therapeutics's enterprise value was $16.43M on Nov 11, 2026, against $43.04M a year earlier. Over the last 5 years it ranged from -$23.50M to $52.97M, with a median of $15.91M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$16.43M-65.0%
2025Dec 31, 2025$46.99M+13.4%
2024Dec 31, 2024$41.45M+276.7%
2023Dec 29, 2023$11.00M–
2022Dec 30, 2022-$9.49M–
2021Dec 31, 2021-$20.89M-187.6%
2020Dec 31, 2020$23.84M+154.0%
2019Apr 30, 2019$9.39M+4.6%
2018Dec 31, 2018$8.97M-11.8%
2017Dec 29, 2017$10.17M-23.7%
2016Dec 30, 2016$13.32M–

More Grace Therapeutics figures

See a number that looks wrong?